-+ 0.00%
-+ 0.00%
-+ 0.00%

Evonik invests over CAD 150 million in Vancouver lipid drug delivery GMP plant expansion

PUBT·08/27/2026 19:20:39
Listen to the news
Evonik invests over CAD 150 million in Vancouver lipid drug delivery GMP plant expansion
  • Evonik will invest over CAD 150 million to build a new GMP lipid-based drug product manufacturing facility in Vancouver.
  • Project backed by up to CAD 68 million in Canadian federal Strategic Response Fund support.
  • Facility will more than triple local capacity for lipid nanoparticle development, clinical drug product manufacturing, quality control, microbiological testing.
  • Production start targeted for end-2029, expanding supply for vaccines, therapeutics, other advanced medicines using lipid delivery.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.